FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/26/2024
Back to search
Official data from USPTO
NATURALIFE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NATURALIFE
ST13
US500000079289279Class
9, 10, 42, 44
Filing
79289279
Registration
7232401
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
53
Latest update
03/26/2024
Trademark type
Word
Nice classes
9, 10, 42, 44
Filing date
06/09/2020
Registration date
12/05/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/05/2023
Last transaction
12/05/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
US
Examiner
BRADLEY, EVELYN
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Overture Life, Inc
Representatives
Lindy M. Herman Rutan & Tucker, LLP
Technical classification
Nice Classes
Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Apparatus for scientific and laboratory researchincubators; laboratory apparatus and instrumentsmicrofluidic biochips for gamete denudationfertilizationembryo development and image capturefor research and scientific purposes; scientific instrumentselectronic analyzers for testing and analyzing chemical and biological substances for the presenceabsencequantity of biologics
Class 10
Instruments for medical analysis relating to the treatment of personsmass spectrometers for analyzing biomarkers and identifying metabolomics profilinggenetic blueprintaneuploidy screeninggenetic abnormalities screening and for pregnancy and miscarriage likelihood screening; medical diagnostic apparatus for detecting embryo DNAmetabolitesproteinsmorphological quality assessment of cleavage stage embryos and blastocysts for pregnancy and miscarriage likelihood; medical diagnostic apparatus for diagnosisexamination and monitoring embryos; medical diagnostic apparatus for tracking embryo development; medical diagnostic apparatus for embryo image assessmentspecifically for analyzing microscopy images of developing embryos and medical imaging apparatus for diagnosing medical conditions during the process of in-vitro fertilization and incorporating recorded operating system software
Class 42
Design and testing of new products for others; design and testing for new product development; scientific and technological servicesscientific research; product development in the field of assisted reproductive technologies; design and development of products in the field of embryologyassisted reproductive technologies research; development of new products; scientific research and development; development of medical testing methods; product development analysis; product development evaluation; research and development of new products; design and development of medical technology; biological research; clinical research in the field of in vitro fertilizationclinical reproduction and medical diagnostics; medical research; scientific research with a medical purpose; research and development in the field of pharmacy and biotechnology; development and design of new products; scientific and technological design in the field of assisted reproductive technologies; specialized machinery design; design of new products; new product design; scientific research and design in the field of in vitro fertilizationautomatic time-lapse incubatorsmicroscopesmicromanipulatorsembryo culturelabwaregamete processing methods; research relating to design in the field of assisted reproductive technologies; medical research relating to human tissue; medical and scientific researchconducting clinical trials for others; clinical studies being clinical research in the field of in Vitro Fertilizationembryologyclinical reproductionfertility and infertility services and medical diagnostic; clinical research in the field of tissue engineering of artificial placenta; artificial endometrium research in the field of pharmacogenetics; medical research; medical laboratory services; biomedical research services; technological analysis and evaluation of products during product development to determine efficacy and conformity with certification standards; computer aided design of molds
Class 44
In vitro fertilization services; medical servicesspecificallyin-vitro fertilization; analysis of human tissues for medical treatment; medical analysis for the diagnosis and treatment of people; medical consultancy in the field of pregnancy; medical assistance; medical care; medical consultations; gynecological cytology services; medical examination for persons; medical information; medical analysis services for diagnostic and treatment purposes; medical and healthcare services related to DNAgenetics and genetic testing; sperm bank services; human fertility treatment services; pregnancy testing services
Publications
History of USPTO decisions and trademark events.
53 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/05/2024
FIMP
FINAL DISPOSITION PROCESSED
03/05/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/05/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/05/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
12/05/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/19/2023
PUBO
PUBLISHED FOR OPPOSITION
09/19/2023
GPNX
NOTIFICATION PROCESSED BY IB
09/17/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/30/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/30/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/30/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/16/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
08/12/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/12/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
08/12/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/12/2023
GNS1
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
01/20/2023
GNSF
SUBSEQUENT FINAL EMAILED
01/20/2023
CFRC
SUBSEQUENT FINAL REFUSAL WRITTEN
01/20/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
11/21/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
11/08/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/12/2022
GNSL
LETTER OF SUSPENSION E-MAILED
04/12/2022
CNSL
SUSPENSION LETTER WRITTEN
04/12/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/23/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/22/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
02/22/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/01/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/15/2021
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/15/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/20/2021
GNFR
FINAL REFUSAL E-MAILED
08/20/2021
CNFR
FINAL REFUSAL WRITTEN
08/20/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/14/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/13/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/13/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/13/2021
GNRT
NON-FINAL ACTION E-MAILED
01/13/2021
CNRT
NON-FINAL ACTION WRITTEN
01/13/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/03/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/02/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/02/2020
RFNT
REFUSAL PROCESSED BY IB
10/25/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/08/2020
RFRR
REFUSAL PROCESSED BY MPU
10/08/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/20/2020
CNRT
NON-FINAL ACTION WRITTEN
09/19/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/18/2020
DOCK
ASSIGNED TO EXAMINER
09/10/2020
MAFR
APPLICATION FILING RECEIPT MAILED
07/14/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/10/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/09/2020
Continuous trademark protection
Get notified about every new filing that threatens NATURALIFE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.